European Myeloma Network B.v.

This study is testing an investigational drug called teclistamab in people with AL amyloidosis who have already tried other treatments. The goal is to see if teclistamab can effectively reduce the harmful proteins produced by the disease. Researchers will measure how many partici…

This large Phase 3 study is testing whether adding a new drug called teclistamab to standard maintenance therapy (lenalidomide) works better than lenalidomide alone for people with newly diagnosed multiple myeloma who have had a stem cell transplant. The goal is to help keep the …

This large, late-stage study is testing whether adding an experimental drug called linvoseltamab to a standard treatment regimen works better for controlling multiple myeloma. It will involve 1,000 adults newly diagnosed with this blood cancer who are not candidates for a stem ce…

This study aims to collect and store blood and tissue samples from 6,000 patients with multiple myeloma and related conditions. Researchers will gather samples and track treatment information over time to create a resource for future studies. The goal is to help scientists better…